VRS
ATRA icon

Virginia Retirement Systems’s Atara Biotherapeutics ATRA Stock Holding History

Virginia Retirement Systems’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-504
Closed -$199K – 1117
2021
Q4 		$199K Sell
504
-160
-24% -$67.4K ﹤0.01% 1062
2021
Q3 		$297K Buy
664
+24
+4% +$8.6K ﹤0.01% 886
2021
Q2 		$249K Buy
+640
New +$228K ﹤0.01% 958

Other funds holding ATRA

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Virginia Retirement Systems's ATRA Position: Q1 2022 in Review

Virginia Retirement Systems sold out of Atara Biotherapeutics (ATRA) in Q1 2022, closing a stake of 504 shares — an estimated $199K sold.

Virginia Retirement Systems first reported a position in ATRA in Q2 2021 and held it in 3 quarters. The position peaked at $297K in Q3 2021. 144 funds tracked by Wall St. Rank hold ATRA as of Q1 2022.

  • Virginia Retirement Systems reported no remaining Atara Biotherapeutics position as of Q1 2022 after selling out during the quarter.
  • Virginia Retirement Systems sold 504 Atara Biotherapeutics shares in Q1 2022, an estimated $199K.
  • Virginia Retirement Systems first reported a position in Atara Biotherapeutics in Q2 2021 and held it in 3 quarters.
  • Virginia Retirement Systems's Atara Biotherapeutics position peaked at $297K in Q3 2021.
  • 144 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q1 2022.

Based on Virginia Retirement Systems's 13F filing for Q1 2022, filed 21 Apr 2022.